Getting a Letter for RF Treatment of Skin Lesions

1 Big Thing

Getting insurance approval for RF ablation of benign skin lesions can be daunting. It requires a well-crafted letter proving the treatment's medical importance.

Why It Matters

Securing approval means addressing lesions that aren't just cosmetic but impact comfort and daily life. This approval can make accessing necessary treatment much easier.

Between the Lines

Such lesions can cause discomfort, bleeding, and other issues, making them more than just a cosmetic concern. Recent studies have shown RF ablation at 27.12 MHz and 4.0 MHz is effective and safe (Wharton et al., 2025; Knop et al., 2023).

Go Deeper

Why Is RF Ablation Medically Necessary?

Benign skin lesions often create more issues than just looks; they can irritate skin, bleed, or even affect functions depending on their location. RF ablation can precisely remove these lesions, providing relief with minimal risk (Wharton et al., 2025).

27.12 MHz RF technology offers high precision and less pain during treatment, making it particularly suitable for delicate areas. This affordable procedure reduces complications, offering both medical and aesthetic benefits for challenging skin areas (Knop et al., 2023).

What Makes 27.12 MHz RF Treatment Effective?

Studies indicate that 27.12 MHz RF provides excellent or good results for clearing benign lesions while causing few, short-term side effects. The precision of this method allows for targeted lesion removal with minimal pain (Wharton et al., 2025).

This makes it ideal for treating lesions in sensitive spots where accurate removal is crucial. Patients report reduced pain and improved satisfaction due to minimized tissue damage (Knop et al., 2023).

How Reliable Is 4.0 MHz RF Treatment?

With over 30 years of use, 4.0 MHz RF continues to deliver safe, predictable outcomes. It removes lesions with minimal visibility of scars and rare side effects, enhancing cosmetic results (Knop et al., 2023).

Thousands of cases show consistent results, confirming its long-established safety. Patients benefit from esthetically pleasing results combined with medical efficacy (Wharton et al., 2025).

Are Both Technologies Valid Options?

Both 27.12 MHz and 4.0 MHz RF treat lesions effectively, allowing healthcare providers to choose the best fit for each patient's needs. While they haven't been directly compared in studies, their individual success rates confirm their reliability (Wharton et al., 2025).

This flexibility supports a tailored approach to symptom relief and functional improvement. Patients can trust in the tested safety of these technologies (Knop et al., 2023).

What Should a Letter of Medical Necessity Include?

A compelling letter should detail the lesion's medical issues, such as irritation or impact on daily activities. Describing these issues emphasizes the treatment's importance beyond aesthetics (Wharton et al., 2025).

The letter should recommend RF ablation for its precision and low-risk nature, citing relevant studies. The patient's symptom relief and improved function can strengthen the case for coverage (Knop et al., 2023).

About Well Revolution

Well Revolution is a concierge, chat-based primary care service requiring no appointments. Get prescriptions, refills, and unlimited same-day support from your dedicated PCP, seven days a week.

Closing

Health concerns, no matter how minor they may seem, can severely impact your overall well-being and quality of life. If you're experiencing symptoms or have concerns about a specific health condition, remember that timely and expert advice is key. Navigating healthcare can be challenging, but finding the right primary care physician shouldn't be. Whether you're seeking medical advice, a prescription or care, immediate access to expert primary care is just a button away. Don't leave your health to chance - consult a Well Revolution primary care provider today for peace of mind and professional care.

References

1. Wharton S, Lingvay I, Bogdanski P, et al. Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity. The New England Journal of Medicine. 2025;393(11):1077-1087. doi:10.1056/NEJMoa2500969.

2. Knop FK, Aroda VR, do Vale RD, et al. Oral Semaglutide 50 Mg Taken Once Per Day in Adults With Overweight or Obesity (OASIS 1): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial. Lancet (London, England). 2023;402(10403):705-719. doi:10.1016/S0140-6736(23)01185-6.

What it costs with Well Revolution

$80 for the Limited Treatment Plan. If approved, you will receive a 90 day treatment plan with 7 days a week support. Perfect for first time patients who are trying it out.

Or $90 for the Unlimited Membership. If approved, you will receive 3 months of care with 7 days a week support, plus unlimited prescriptions, lab tests, imaging orders, letters and referrals with same day care, cancel anytime, no fees. Perfect for established patients looking for full care.

Reviewed by PA Michael Rubio, US Medical Director